The rise of Sildenafil initially sparked a boom for major pharmaceutical companies, however recent changes present a uncertain picture for investors. Generic versions are eroding earnings, and ongoing patent challenges https://lucsssk295699.jts-blog.com/39805870/sildenafil-and-big-pharma-a-volatile-investment